Document Top

  • BRiTE: effect of Avastin on PFS and OS

    AVF2107g: first‐ line PFS benefit with Avastin

        

     More

  • First-BEAT: safety of Avastin in elderly patients

    NO16966: first‐line PFS benefit with Avastin

      

     More

  • First-line Avastin in combination with irinotecan-based chemotherapy

    E3200: second‐ line PFS benefit with Avastin

      

     More

  • AVF2107g: effect of Avastin on ORR and duration of response

    First‐BEAT: Avastin in routine clinical practice

      

     More

 

Patient cases

Physicians share their experience and discuss  treatment options for patients with mCRC.
The case presentations are designed to provide an insight into clinical practice and treatment decisions supported by trial data.

More

LATEST PATIENT CASES

Educational webcasts

Educational webcasts

A series of webcasts highlighting some of the key learning points from scientific and clinical data.
Experienced physicians and scientists share their thoughts on the development of anticancer agents and discuss the options available for the treatment of mCRC.

More

LATEST WEBCAST

  • Expert perspectives in CRC

    Expert perspectives in CRC

    Impact of Avastin in CRC (Prof Eric van Cutsem)

    View

  • Angiogenesis, VEGF and the MoA of Avastin

    Angiogenesis, VEGF and the MoA of Avastin

    Precise VEGF inhibition with Avastin is a proven anti-tumour strategy

    View

  • Expert perspective

    Expert perspective

    Targeting angiogenesis (Prof Joaquin Bellmunt)

    View

Watch more

  • Outcomes in potentially resectable patients

    Outcomes in potentially resectable patients

    Discussion of treatment of mCRC patients with liver metastases, according to resectability status (Prof Thomas Gruenberger)

    View

  • Challenges in the treatment of mCRC

    Challenges in the treatment of mCRC

    Educational Webcast - Challenges in the treatment of mCRC (Prof Dirk Arnold)

    View

  • Optimising mCRC treatment options

    Optimising mCRC treatment options

    A discussion of utilising current treatment options to provide optimal treatment strategies and improved outcomes for patients with mCRC (Dr Axel Grothey)

    View

Watch more

  • CRC patient case

    CRC patient case

    A patient with rectal adenocarcinoma and unresectable liver metastases (Prof Michel Ducreux)

    View

  • CRC patient case

    CRC patient case

    A patient with colon adenocarcinoma with borderline resectable liver-only metastases (Dr Mark Kozloff)

    View

Watch more

Upcoming Conferences

  • USA
    AACR
    ,
    Chicago, IL, USA
    31 March 2012 - 04 April 2012
  • Spain
    EONS
    ,
    Valencia, Spain
    26-27 April 2012
  • Spain
    EACR
    ,
    Barcelona, Spain
    7-10 July 2012

More upcoming conferences

x

You are now leaving the www.avastin.net website. Links to all external sites are provided as a resource to our visitors. Hoffmann-La Roche Inc. ("Roche") accepts no responsibility for the content of these sites. Roche does not control these sites, and the opinions, claims, or comments expressed on these sites should not be attributed to Roche, except where indicated. We recommend that you consult with your physician or other healthcare provider to obtain more information about any Roche prescription medication.

OK Cancel